# Tyson Foods, Inc.: financial statements, quarterly

TSN · NYSE · CIK 100493 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/tsn.md) · [Financials](/companies/tsn/financials.md) · [Filings](/companies/tsn/filings.md) · [Insiders](/companies/tsn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tsn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [13.3 d](/filings/0000100493-25-000095.md) | [13.3](/filings/0000100493-25-000007.md) | [13.1](/filings/0000100493-25-000056.md) | [13.4](/filings/0000100493-25-000076.md) | [13.6 d](/filings/0000100493-25-000095.md) | [13.6](/filings/0000100493-26-000007.md) | [13.1](/filings/0000100493-26-000020.md) | [13.9](/filings/0000100493-26-000058.md) | [13.9 d](/filings/0000100493-25-000095.md) | [14.3](/filings/0000100493-26-000007.md) | [13.7](/filings/0000100493-26-000020.md) | [13.9](/filings/0000100493-26-000058.md) |
| Cost of revenue | $bn | [12.9 d](/filings/0000100493-25-000095.md) | [12.5](/filings/0000100493-25-000007.md) | [12.2](/filings/0000100493-25-000056.md) | [12.5](/filings/0000100493-25-000076.md) | [12.5 d](/filings/0000100493-25-000095.md) | [12.5](/filings/0000100493-26-000007.md) | [12.5](/filings/0000100493-26-000020.md) | [12.7](/filings/0000100493-26-000058.md) | [13.1 d](/filings/0000100493-25-000095.md) | [13.5](/filings/0000100493-26-000007.md) | [12.7](/filings/0000100493-26-000020.md) | [12.9](/filings/0000100493-26-000058.md) |
| Gross profit | $bn | [0.5 d](/filings/0000100493-25-000095.md) | [0.8](/filings/0000100493-25-000007.md) | [0.9](/filings/0000100493-25-000056.md) | [0.9](/filings/0000100493-25-000076.md) | [1.1 d](/filings/0000100493-25-000095.md) | [1.1](/filings/0000100493-26-000007.md) | [0.6](/filings/0000100493-26-000020.md) | [1.1](/filings/0000100493-26-000058.md) | [0.7 d](/filings/0000100493-25-000095.md) | [0.8](/filings/0000100493-26-000007.md) | [1.0](/filings/0000100493-26-000020.md) | [0.9](/filings/0000100493-26-000058.md) |
| Selling, general and administrative | $bn | [0.6 d](/filings/0000100493-25-000095.md) | [0.6](/filings/0000100493-25-000007.md) | [0.6](/filings/0000100493-25-000056.md) | [0.5](/filings/0000100493-25-000076.md) | [0.5 d](/filings/0000100493-25-000095.md) | [0.5](/filings/0000100493-26-000007.md) | [0.5](/filings/0000100493-26-000020.md) | [0.5](/filings/0000100493-26-000058.md) | [0.6 d](/filings/0000100493-25-000095.md) | [0.5](/filings/0000100493-26-000007.md) | [0.5](/filings/0000100493-26-000020.md) | [0.6](/filings/0000100493-26-000058.md) |
| Operating income | $bn | [(0.5) d](/filings/0000100493-25-000095.md) | [0.2](/filings/0000100493-25-000007.md) | [0.3](/filings/0000100493-25-000056.md) | [0.3](/filings/0000100493-25-000076.md) | [0.5 d](/filings/0000100493-25-000095.md) | [0.6](/filings/0000100493-26-000007.md) | [0.1](/filings/0000100493-26-000020.md) | [0.3](/filings/0000100493-26-000058.md) | [0.2 d](/filings/0000100493-25-000095.md) | [0.3](/filings/0000100493-26-000007.md) | [0.4](/filings/0000100493-26-000020.md) | [0.4](/filings/0000100493-26-000058.md) |
| Interest expense | $bn | [0.1 d](/filings/0000100493-25-000095.md) | [0.1](/filings/0000100493-24-000014.md) | [0.1](/filings/0000100493-24-000069.md) | [0.1](/filings/0000100493-25-000076.md) | [0.1 d](/filings/0000100493-25-000095.md) | [0.1](/filings/0000100493-26-000007.md) | [0.1](/filings/0000100493-26-000020.md) | [0.1](/filings/0000100493-26-000058.md) | [0.1 d](/filings/0000100493-25-000095.md) | [0.1](/filings/0000100493-26-000007.md) | [0.1](/filings/0000100493-26-000020.md) | [0.1](/filings/0000100493-26-000058.md) |
| Income tax | $bn | [(0.1) d](/filings/0000100493-25-000095.md) | [0.0](/filings/0000100493-25-000007.md) | [0.1](/filings/0000100493-25-000056.md) | [0.1](/filings/0000100493-25-000076.md) | [0.1 d](/filings/0000100493-25-000095.md) | [0.1](/filings/0000100493-26-000007.md) | [0.0](/filings/0000100493-26-000020.md) | [0.1](/filings/0000100493-26-000058.md) | [0.0 d](/filings/0000100493-25-000095.md) | [0.0](/filings/0000100493-26-000007.md) | [0.1](/filings/0000100493-26-000020.md) | [0.1](/filings/0000100493-26-000058.md) |
| Net income | $bn | [(0.5) d](/filings/0000100493-25-000095.md) | [0.1](/filings/0000100493-25-000007.md) | [0.1](/filings/0000100493-25-000056.md) | [0.2](/filings/0000100493-25-000076.md) | [0.4 d](/filings/0000100493-25-000095.md) | [0.4](/filings/0000100493-26-000007.md) | [0.0](/filings/0000100493-26-000020.md) | [0.1](/filings/0000100493-26-000058.md) | [0.0 d](/filings/0000100493-25-000095.md) | [0.1](/filings/0000100493-26-000007.md) | [0.3](/filings/0000100493-26-000020.md) | [0.2](/filings/0000100493-26-000058.md) |
| Diluted EPS | $ per share | not reported | [0.30](/filings/0000100493-25-000007.md) | [0.41](/filings/0000100493-25-000056.md) | [0.54](/filings/0000100493-25-000076.md) | not reported | [1.01](/filings/0000100493-26-000007.md) | [0.02](/filings/0000100493-26-000020.md) | [0.17](/filings/0000100493-26-000058.md) | not reported | [0.24](/filings/0000100493-26-000007.md) | [0.73](/filings/0000100493-26-000020.md) | [0.52](/filings/0000100493-26-000058.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.6](/filings/0000100493-25-000095.md) | [1.5](/filings/0000100493-25-000007.md) | [2.2](/filings/0000100493-25-000056.md) | [2.6](/filings/0000100493-25-000076.md) | [1.7](/filings/0000100493-25-000095.md) | [2.3](/filings/0000100493-26-000007.md) | [1.0](/filings/0000100493-26-000020.md) | [1.5](/filings/0000100493-26-000058.md) | [1.2](/filings/0000100493-26-000058.md) | [1.3](/filings/0000100493-26-000007.md) | [0.5](/filings/0000100493-26-000020.md) | [0.7](/filings/0000100493-26-000058.md) |
| Current assets | $bn | [8.7](/filings/0000100493-24-000119.md) | [9.2](/filings/0000100493-24-000014.md) | [10.0](/filings/0000100493-24-000069.md) | [10.6](/filings/0000100493-24-000103.md) | [9.8](/filings/0000100493-25-000095.md) | [10.1](/filings/0000100493-25-000007.md) | [9.2](/filings/0000100493-25-000056.md) | [9.9](/filings/0000100493-25-000076.md) | [9.9](/filings/0000100493-26-000058.md) | [9.5](/filings/0000100493-26-000007.md) | [8.9](/filings/0000100493-26-000020.md) | [9.5](/filings/0000100493-26-000058.md) |
| Total assets | $bn | [36.3](/filings/0000100493-25-000095.md) | [36.7](/filings/0000100493-24-000014.md) | [37.5](/filings/0000100493-24-000069.md) | [37.7](/filings/0000100493-24-000103.md) | [37.1](/filings/0000100493-25-000095.md) | [37.3](/filings/0000100493-26-000007.md) | [36.3](/filings/0000100493-26-000020.md) | [36.5](/filings/0000100493-26-000058.md) | [36.7](/filings/0000100493-26-000058.md) | [36.0](/filings/0000100493-26-000007.md) | [35.2](/filings/0000100493-26-000020.md) | [35.6](/filings/0000100493-26-000058.md) |
| Current liabilities | $bn | [6.5](/filings/0000100493-24-000119.md) | [6.2](/filings/0000100493-24-000014.md) | [5.6](/filings/0000100493-24-000069.md) | [5.8](/filings/0000100493-24-000103.md) | [4.8](/filings/0000100493-25-000095.md) | [4.8](/filings/0000100493-25-000007.md) | [5.5](/filings/0000100493-25-000056.md) | [5.7](/filings/0000100493-25-000076.md) | [6.4](/filings/0000100493-26-000058.md) | [6.2](/filings/0000100493-26-000007.md) | [4.8](/filings/0000100493-26-000020.md) | [6.6](/filings/0000100493-26-000058.md) |
| Current portion of debt | $bn | [1.9](/filings/0000100493-24-000119.md) | [1.3](/filings/0000100493-24-000014.md) | [1.3](/filings/0000100493-24-000069.md) | [1.3](/filings/0000100493-24-000103.md) | [0.1](/filings/0000100493-25-000095.md) | [0.1](/filings/0000100493-25-000007.md) | [0.9](/filings/0000100493-25-000056.md) | [0.9](/filings/0000100493-25-000076.md) | [0.9](/filings/0000100493-26-000058.md) | [0.9](/filings/0000100493-26-000007.md) | [0.1](/filings/0000100493-26-000020.md) | [1.4](/filings/0000100493-26-000058.md) |
| Shareholders' equity | $bn | [18.1](/filings/0000100493-24-000119.md) | [18.2](/filings/0000100493-24-000014.md) | [18.1](/filings/0000100493-24-000069.md) | [18.1](/filings/0000100493-24-000103.md) | [18.4](/filings/0000100493-25-000095.md) | [18.5](/filings/0000100493-25-000007.md) | [18.4](/filings/0000100493-25-000056.md) | [18.3](/filings/0000100493-25-000076.md) | [18.1](/filings/0000100493-26-000058.md) | [18.0](/filings/0000100493-26-000007.md) | [18.1](/filings/0000100493-26-000020.md) | [18.1](/filings/0000100493-26-000058.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-09-27) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [323 d](/filings/0000100493-25-000095.md) | [1,300](/filings/0000100493-25-000007.md) | [(123) d](/filings/0000100493-25-000056.md) | [796 d](/filings/0000100493-25-000076.md) | [617 d](/filings/0000100493-25-000095.md) | [1,031](/filings/0000100493-26-000007.md) | [(185) d](/filings/0000100493-26-000020.md) | [774 d](/filings/0000100493-26-000058.md) | [535 d](/filings/0000100493-25-000095.md) | [942](/filings/0000100493-26-000007.md) | [(113) d](/filings/0000100493-26-000020.md) | [640 d](/filings/0000100493-26-000058.md) |
| Capital expenditure | $m | [375 d](/filings/0000100493-25-000095.md) | [354](/filings/0000100493-25-000007.md) | [267 d](/filings/0000100493-25-000056.md) | [263 d](/filings/0000100493-25-000076.md) | [248 d](/filings/0000100493-25-000095.md) | [271](/filings/0000100493-26-000007.md) | [193 d](/filings/0000100493-26-000020.md) | [227 d](/filings/0000100493-26-000058.md) | [287 d](/filings/0000100493-25-000095.md) | [252](/filings/0000100493-26-000007.md) | [145 d](/filings/0000100493-26-000020.md) | [159 d](/filings/0000100493-26-000058.md) |
| Dividends paid | $m | [167 d](/filings/0000100493-25-000095.md) | [171](/filings/0000100493-25-000007.md) | [171 d](/filings/0000100493-25-000056.md) | [171 d](/filings/0000100493-25-000076.md) | [171 d](/filings/0000100493-25-000095.md) | [175](/filings/0000100493-26-000007.md) | [174 d](/filings/0000100493-26-000020.md) | [175 d](/filings/0000100493-26-000058.md) | [173 d](/filings/0000100493-25-000095.md) | [177](/filings/0000100493-26-000007.md) | [176 d](/filings/0000100493-26-000020.md) | [176 d](/filings/0000100493-26-000058.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-04-01) | Q3 FY2023 (2023-07-01) | Q1 FY2024 (2023-12-30) | Q2 FY2024 (2024-03-30) | Q3 FY2024 (2024-06-29) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q1 FY2026 (2025-12-27) | Q2 FY2026 (2026-03-28) | Q3 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [358](/filings/0000100493-24-000014.md) | [284](/filings/0000100493-24-000069.md) | [284](/filings/0000100493-24-000103.md) | [355](/filings/0000100493-25-000007.md) | [355](/filings/0000100493-25-000056.md) | [356](/filings/0000100493-25-000076.md) | [357](/filings/0000100493-26-000007.md) | [357](/filings/0000100493-26-000020.md) | [357](/filings/0000100493-26-000058.md) | [354](/filings/0000100493-26-000007.md) | [354](/filings/0000100493-26-000020.md) | [355](/filings/0000100493-26-000058.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.